SCHEMBL18948571

SCHEMBL18948571

Bc1ccc(C(=O)Nc2cc(F)c(F)c(F)c2)cc1S(=O)(=O)N1CCC(O)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.61
▸ CYP2D6 P10635 3/20 0.61
▸ CYP2C9 P11712 3/20 0.61
▸ CYP2C19 P33261 3/20 0.61
▸ KCNH2 Q12809 2/20 0.61
▸ CYP1A2 P05177 2/20 0.61
▸ MAPT P10636 8/20 0.53
▸ TP53 P04637 5/20 0.53
▸ LMNA P02545 3/20 0.51
▸ TSHR P16473 2/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ HTT P42858 2/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ POLB P06746 2/20 0.47
▸ THRB P10828 1/20 0.47
▸ ENPP2 Q13822 2/20 0.45
▸ LPAR1 Q92633 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15076711 0.90 CYP3A4 (0.67) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL15076488 0.88 CYP3A4 (0.62) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL15076702 0.88 THRB (0.62) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL15277119 0.88 CYP3A4 (0.61) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL21623329 0.88 CYP3A4 (0.70) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL20647730 0.87 MAPT (0.66) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL16903008 0.87 MAPT (0.66) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL21623242 0.86 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL17124867 0.86 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL15076525 0.86 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676747-B2 Hepatitis B antiviral agents NOVIRA THERAPEUTICS, INC. (US) 2017-06-13 — — US disclosed
Send feedback